Soleno Therapeutics (SLNO) had the highest return between August 12, 2023 and November 1, 2023 by a mid-cap US stock, returning 409.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 8/12/2023 - 11/1/2023 | 409.77% |
Crinetics Pharmaceuticals (CRNX) | 8/12/2023 - 11/1/2023 | 81.07% |
Immunitybio (IBRX) | 8/12/2023 - 11/1/2023 | 78.57% |
Scholar Rock (SRRK) | 8/12/2023 - 11/1/2023 | 74.96% |
Belite Bio Inc ADR (BLTE) | 8/12/2023 - 11/1/2023 | 71.3% |
Abercrombie & Fitch (ANF) | 8/12/2023 - 11/1/2023 | 57.01% |
Immunovant (IMVT) | 8/12/2023 - 11/1/2023 | 51.79% |
Apellis Pharmaceuticals (APLS) | 8/12/2023 - 11/1/2023 | 51.44% |
Uranium Energy (UEC) | 8/12/2023 - 11/1/2023 | 51.44% |
Stride (LRN) | 8/12/2023 - 11/1/2023 | 40.1% |
HUTCHMED DRC (HCM) | 8/12/2023 - 11/1/2023 | 38.79% |
BW LPG (BWLP) | 8/12/2023 - 11/1/2023 | 37.58% |
Miniso Group Holding (MNSO) | 8/12/2023 - 11/1/2023 | 36.72% |
Frontline (FRO) | 8/12/2023 - 11/1/2023 | 36.26% |
Dlocal (DLO) | 8/12/2023 - 11/1/2023 | 35.29% |
Up Fintech (TIGR) | 8/12/2023 - 11/1/2023 | 28.41% |
New Oriental Education & Technology (EDU) | 8/12/2023 - 11/1/2023 | 27.19% |
USA Compression Partners (USAC) | 8/12/2023 - 11/1/2023 | 26.8% |
Elastic (ESTC) | 8/12/2023 - 11/1/2023 | 26.62% |
Torm PLC Class A (TRMD) | 8/12/2023 - 11/1/2023 | 26.05% |
Gap (GAP) | 8/12/2023 - 11/1/2023 | 26.02% |
Grindr (GRND) | 8/12/2023 - 11/1/2023 | 25.16% |
Nuvalent (NUVL) | 8/12/2023 - 11/1/2023 | 25.1% |
TAL Education (TAL) | 8/12/2023 - 11/1/2023 | 25.07% |
NexGen Energy (NXE) | 8/12/2023 - 11/1/2023 | 23.88% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
